Plowman P N, Pizer B, Kingston J E
Department of Clinical Oncology, St Bartholomew's Hospital, London, UK.
Clin Oncol (R Coll Radiol). 2004 Jun;16(4):244-7. doi: 10.1016/j.clon.2003.12.005.
This report relates to a retrospective analysis of two non-randomised cohorts of patients with pineoblastoma, with some differences in presenting features and treatment characteristics. We have identified a large difference in survival depending on the possession or otherwise of the mutated RB (retinoblastoma) gene in the genome/karyotype. Eight children with familial retinoblastoma (non-metastatic at presentation) developed pineoblastoma and were treated by chemotherapy and radiotherapy. The survival of these patients was compared with the survival of nine non-metastatic sporadic cases of pineoblastoma similarly staged and treated. One out of eight children having the RB mutation in the genome survived compared with seven out of nine in the group with sporadic pineoblastoma (P = 0.002). It is suggested that the inheritance of the mutated retinoblastoma gene is not only causal in the generation of this tumour type but, in a way that is yet to be defined, renders such tumours more aggressive or less responsive to therapy. With the current interest in the role of RB mutations in other cancers (where the prognostic import of single genes is less easily identified), this observation may have wider relevance.
本报告涉及对两个非随机成视网膜细胞瘤患者队列的回顾性分析,这两个队列在呈现特征和治疗特点上存在一些差异。我们发现,根据基因组/核型中是否存在突变的RB(视网膜母细胞瘤)基因,患者的生存率存在很大差异。八名患有家族性视网膜母细胞瘤(就诊时无转移)的儿童患上了成视网膜细胞瘤,并接受了化疗和放疗。将这些患者的生存率与九例分期和治疗相似的非转移性散发性成视网膜细胞瘤病例的生存率进行了比较。基因组中存在RB突变的八名儿童中有一名存活,而散发性成视网膜细胞瘤组的九名儿童中有七名存活(P = 0.002)。研究表明,视网膜母细胞瘤基因突变的遗传不仅是这种肿瘤类型产生的原因,而且以一种尚待确定的方式使此类肿瘤更具侵袭性或对治疗反应性更低。鉴于目前对RB突变在其他癌症中的作用的关注(在其他癌症中单个基因的预后重要性不太容易确定),这一观察结果可能具有更广泛的相关性。